Epithelial Abnormalities in the High-Risk Fallopian Tube of a Rare TP53 / BRCA2 Li-Fraumeni Syndrome Patient With Multiple Tumors
Open Access
- 1 June 2025
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 9 (9) , e2400589
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohortCancer, 2016
- Li-Fraumeni syndrome: cancer risk assessment and clinical managementNature Reviews Clinical Oncology, 2014
- The Li–Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tubeThe Journal of Pathology, 2009
- Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutationsGynecologic Oncology, 2008
- Primary Fallopian Tube Malignancies in BRCA-Positive Women Undergoing Surgery for Ovarian Cancer Risk ReductionJournal of Clinical Oncology, 2007
- A candidate precursor to serous carcinoma that originates in the distal fallopian tubeThe Journal of Pathology, 2006
- The reproductive significance of human Fallopian tube ciliaHuman Reproduction Update, 2006
- The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer SyndromeAmerican Journal of Surgical Pathology, 2006
- Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.2003
- Cell cycle‐related proteins p21 and bcl‐2: markers of differentiation in the human Fallopian tubeHistopathology, 2001